Paraneoplastic Pemphigus Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Paraneoplastic Pemphigus
Paraneoplastic Pemphigus (PNP) is a challenging and often life-threatening autoimmune condition. Unlike other forms of pemphigus, PNP is uniquely associated with an underlying cancer, which can be benign or malignant. This connection means the body's immune system mistakenly attacks its own tissues, leading to painful blisters and erosions on the skin and, crucially, on mucous membranes like the mouth, eyes, and genitals. The severity of these lesions can significantly impact a patient's quality of life, making eating, speaking, and even breathing difficult. Diagnosis can be complex, often requiring specialized tests like immunofluorescence to detect specific antibodies.
Managing PNP involves two primary strategies: treating the underlying cancer and suppressing the autoimmune response. The first step is to identify and treat the associated tumor, as its removal or control can sometimes lead to an improvement in PNP symptoms. For the autoimmune component, common treatments include high-dose corticosteroids (such as prednisone) to reduce inflammation and suppress the immune system. When corticosteroids alone are insufficient or to minimize their long-term side effects, other immunosuppressants like azathioprine, mycophenolate mofetil, or cyclophosphamide may be prescribed. Biologic therapies, such as rituximab, which targets specific immune cells, and intravenous immunoglobulin (IVIG), are also frequently used, especially in severe or refractory cases
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.